Treatment of obsessive-compulsive disorders with 5-ht2...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/445 (2006.01)

Patent

CA 2183954

The present invention is directed to 5-HT2 antagonists end their use as agents in the treatment of obsessive-compulsive disorders (OCD). The invention is particularly directed to the compound (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol which is a member of a class of 5-HT2 antagonists known as N-aralkyl piperidinemethanol derivatives which are potent and selective inhibitors of the binding of serotonin at the 5-HT2 receptor site.

La présente invention se rapporte à des antagonistes de 5-HT2 et à leur utilisation comme agents dans le traitement des psychonévroses obsessionnelles. L'invention se rapporte notamemnt au composé (+)- alpha -(2,3-diméthoxyphényl)-1-[2-(4-fluorophényl)éthyl]-4-piperidineméthanol, élément d'une classe d'antagonistes 5-HT2 connus comme étant des dérivés de N-aralkyle piperidineméthanol, lesquels sont des inhibiteurs puissants et sélectifs de la fixation de la sérotonine sur le site du récepteur 5-HT2.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of obsessive-compulsive disorders with 5-ht2... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of obsessive-compulsive disorders with 5-ht2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of obsessive-compulsive disorders with 5-ht2... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2000971

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.